A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)
Clinical trial NCT07547228 · RECRUITING
Trial details
- NCT number
- NCT07547228
- Sponsor
- Intra-IMMUSG Pte Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-11
- Primary completion
- 2027-02-07
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.